Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study

The Lancet Psychiatry

Volumn 4, Issue 1, 2017, Pages 33-41

  Kim, Jong S ^a   Lee, Eun Jae ^a   Chang, Dae Il ^b   Park, Jong Ho ^c   Ahn, Seong Hwan ^d   Cha, Jae Kwan ^e   Heo, Ji Hoe ^f   Sohn, Sung Il ^g   Lee, Byung Chul ^h   Kim, Dong Eog ⁱ   Kim, Hahn Young ^j   Kim, Seongheon ^k   Kwon, Do Young ^l   Kim, Jei ^m   Seo, Woo Keun ⁿ   Lee, Jun ^o   Park, Sang Won ^p   Koh, Seong Ho ^q   Kim, Jin Young ^r   Choi Kwon, Smi ^s  

^a University of Ulsan   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Seonam University   (South Korea)

^d Chosun University   (South Korea)

^e Dong A University College of Medicine   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

^g Dongsan Medical Center   (South Korea)

^h Hallym University   (South Korea)

ⁱ Dongguk University Ilsan Hospital   (South Korea)

^j Konkuk University School of Medicine   (South Korea)

^k Kangwon National University College of Medicine   (South Korea)

^l Korea University   (South Korea)

^m Chungnam National University College of Medicine   (South Korea)

ⁿ Sungkyunkwan University   (South Korea)

^o Young Nam University Hospital   (South Korea)

^p Daegu Fatima Hospital   (South Korea)

^q Hanyang University Guri Hospital   (South Korea)

^r Hyundai Hospital   (South Korea)

^s Seoul National University   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; PLACEBO; ANTIDEPRESSANT AGENT; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ABDOMINAL PAIN; ADULT; ANOREXIA; ANXIETY; ARTHRALGIA; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EMOTIONAL DISORDER; EMOTIONAL INCONTINENCE; ERECTILE DYSFUNCTION; FATIGUE; FEMALE; FOLLOW UP; HEART PALPITATION; HUMAN; INDIGESTION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; MYALGIA; NAUSEA; OUTCOME ASSESSMENT; PARESTHESIA; PERIPHERAL EDEMA; PRIORITY JOURNAL; PRURITUS; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOUTH KOREA; SWEAT GLAND DISEASE; TREMOR; WEIGHT GAIN; AGED; CLINICAL TRIAL; DRUG ADMINISTRATION; EMOTION; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PSYCHOLOGY; TREATMENT OUTCOME;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DEPRESSION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EMOTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; SEROTONIN UPTAKE INHIBITORS; STROKE; TREATMENT OUTCOME;

EID: 85008259277     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(16)30417-5     Document Type: Article

References (30)

1. 1 Kim, JS, Choi-Kwon, S, Poststroke depression and emotional incontinence: correlation with lesion location. Neurology 54 (2000), 1805–1810.
2. 2 Kim, JS, Choi, S, Kwon, SU, Seo, YS, Inability to control anger or aggression after stroke. Neurology 58 (2002), 1106–1108.
3. 3 Parikh, RM, Robinson, RG, Lipsey, JR, Starkstein, SE, Fedoroff, JP, Price, TR, The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up. Arch Neurol 47 (1990), 785–789.
4. 4 Kotila, M, Numminen, H, Waltimo, O, Kaste, M, Post-stroke depression and functional recovery in a population-based stroke register. The Finnstroke study. Eur J Neurol 6 (1999), 309–312.
5. 5 Choi-Kwon, S, Kim, HS, Kwon, SU, Kim, JS, Factors affecting the burden on caregivers of stroke survivors in South Korea. Arch Phys Med Rehabil 86 (2005), 1043–1048.
6. 6 Palomaki, H, Kaste, M, Berg, A, et al. Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry 66 (1999), 490–494.
7. 7 Hackett, ML, Anderson, CS, House, A, Halteh, C, Interventions for preventing depression after stroke. Cochrane Database Syst Rev, 3, 2008 CD003689.
8. 8 Robinson, RG, Jorge, RE, Moser, DJ, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 299 (2008), 2391–2400.
9. 9 Choi-Kwon, S, Han, SW, Kwon, SU, Kang, DW, Choi, JM, Kim, JS, Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study. Stroke 37 (2006), 156–161.
10. 10 Dam, M, Tonin, P, De Boni, A, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 27 (1996), 1211–1214.
11. 11 Chollet, F, Tardy, J, Albucher, JF, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 10 (2011), 123–130.
12. 12 Jorge, RE, Acion, L, Moser, D, Adams, HP Jr, Robinson, RG, Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 67 (2010), 187–196.
13. 13 Farrell, B, Godwin, J, Richards, S, Warlow, C, The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 54 (1991), 1044–1054.
14. 14 Winblad, B, Poritis, N, Memantine in severe dementia: results of the 9M-Best Study (benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry 14 (1999), 135–146.
15. 15 Kearns, NP, Cruickshank, CA, McGuigan, KJ, Riley, SA, Shaw, SP, Snaith, RP, A comparison of depression rating scales. Br J Psychiatry 141 (1982), 45–49.
16. 16 Khan, A, Brodhead, AE, Kolts, RL, Relative sensitivity of the Montgomery-Asberg depression rating scale, the Hamilton depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials: a replication analysis. Int Clin Psychopharmacol 19 (2004), 157–160.
17. 17 Kwon, E, Kim, J, Lee, D, Jung, I, A clinical trial of combined treatment with estrogen and antipsychotics in females with chronic schizophrenia. J Korean Soc Biol Psychiatry 5 (1998), 122–128.
18. 18 Brott, T, Adams, HP Jr, Olinger, CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20 (1989), 864–870.
19. 19 Loewen, SC, Anderson, BA, Predictors of stroke outcome using objective measurement scales. Stroke 21 (1990), 78–81.
20. 20 Adams, RJ, Meador, KJ, Sethi, KD, Grotta, JC, Thomson, DS, Graded neurologic scale for use in acute hemispheric stroke treatment protocols. Stroke 18 (1987), 665–669.
21. 21 Nasreddine, ZS, Phillips, NA, Bedirian, V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53 (2005), 695–699.
22. 22 Williams, LS, Weinberger, M, Harris, LE, Clark, DO, Biller, J, Development of a stroke-specific quality of life scale. Stroke 30 (1999), 1362–1369.
23. 23 Scholte op Reimer, WJ, de Haan, RJ, Pijnenborg, JM, Limburg, M, van den Bos, GA, Assessment of burden in partners of stroke patients with the sense of competence questionnaire. Stroke 29 (1998), 373–379.
24. 24 Anderson, CS, Linto, J, Stewart-Wynne, EG, A population-based assessment of the impact and burden of caregiving for long-term stroke survivors. Stroke 26 (1995), 843–849.
25. 25 Kim, JS, Post-stroke mood and emotional disturbances: pharmacological therapy based on mechanisms. J Stroke 18 (2016), 244–255.
26. 26 Hackett, ML, Anderson, CS, House, AO, Management of depression after stroke: a systematic review of pharmacological therapies. Stroke 36 (2005), 1098–1103.
27. 27 Mead, G, Hackett, ML, Lundstrom, E, Murray, V, Hankey, GJ, Dennis, M, The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials. Trials, 16, 2015, 369.
28. 28 Noh, SM, Chung, SJ, Kim, KK, et al. Emotional disturbance in CADASIL: its impact on quality of life and caregiver burden. Cerebrovasc Dis 37 (2014), 188–194.
29. 29 Choi-Kwon, S, Choi, J, Kwon, SU, Kang, DW, Kim, JS, Fluoxetine improves the quality of life in patients with poststroke emotional disturbances. Cerebrovasc Dis 26 (2008), 266–271.
30. 30 Park, S, Kim, MJ, Cho, MJ, Lee, JY, Factors affecting stigma toward suicide and depression: a Korean nationwide study. Int J Soc Psychiatry 61 (2015), 811–817.